Caudal Ventrolateral Medulla Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The caudal ventrolateral medulla (CVLM) is a critical brainstem region that plays an essential role in cardiovascular regulation, autonomic homeostasis, and respiratory control. Located in the ventrolateral medulla oblongata, this region contains neurons that provide inhibitory input to the rostral ventrolateral medulla (RVLM), forming a crucial component of baroreceptor reflex pathways and sympathetic nerve activity modulation[1].
The CVLM is situated in the ventrolateral medulla, caudal to the facial nucleus and rostral to the spinal cord. It extends from approximately the level of the obex to the caudal pole of the inferior olive, lying adjacent to the nucleus of the hypoglossal nerve and the dorsal vagal nucleus[2].
The CVLM contains a heterogeneous population of neurons:
GABAergic projection neurons: The primary output neurons of the CVLM are GABAergic neurons that project to the RVLM, providing tonic and reflex-mediated inhibition of sympathetic premotor neurons[3].
Glycinergic neurons: Some neurons utilize glycine as a neurotransmitter, contributing to fast inhibitory transmission[4].
Glutamatergic interneurons: Local excitatory circuits within the CVLM modulate the activity of projection neurons[5].
Catecholaminergic neurons: A subset of neurons expresses tyrosine hydroxylase (TH) and dopamine-beta-hydroxylase (DBH), contributing to catecholaminergic modulation[6].
The CVLM receives extensive input from cardiovascular and respiratory-related regions:
Nucleus of the solitary tract (NTS): The primary visceral sensory nucleus provides excitatory input to CVLM neurons, mediating baroreceptor reflex integration[7].
Area postrema: This circumventricular organ provides access to circulating hormones and contributes to CVLM modulation[8].
Hypothalamic nuclei: Projections from the paraventricular nucleus (PVN) and other hypothalamic regions provide autonomic modulatory input[9].
Raphe nuclei: Serotonergic inputs influence CVLM neuronal activity[10].
Rostral ventrolateral medulla: The primary target of CVLM GABAergic projections, providing inhibition to sympathetic premotor neurons[11].
Spinal cord: Direct projections to sympathetic preganglionic neurons in the intermediolateral cell column (IML)[12].
Nucleus of the solitary tract: Feedback connections for reflex modulation[13].
CVLM neurons exhibit distinct firing patterns:
Barosensitive neurons: Many CVLM neurons are activated by increased arterial pressure, firing in response to baroreceptor activation[14].
Respiratory-modulated neurons: Some neurons show respiratory-related firing patterns, integrating cardiovascular and respiratory information[15].
Tonic firing neurons: A population exhibits continuous firing that is modulated by various inputs[16].
Voltage-gated calcium channels: T-type and L-type channels contribute to neuronal excitability[17].
Potassium channels: Various potassium conductances shape firing patterns and repolarization[18].
Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels: These channels contribute to resting membrane properties and rhythmic activity[19].
| Neurotransmitter | Markers | Function |
|---|---|---|
| GABA | GAD65/67, VGAT | Primary inhibitory output |
| Glycine | GlyT2, GlyR | Fast inhibition |
| Glutamate | vGluT2, NMDA/AMPA | Excitatory interneurons |
| Catecholamines | TH, DBH | Neuromodulation |
CVLM neurons express diverse receptor types:
Glutamate receptors: NMDA and AMPA receptors mediate excitatory transmission from NTS[20].
GABA receptors: GABA-A and GABA-B receptors regulate neuronal inhibition[21].
Serotonin receptors: Multiple 5-HT receptor subtypes enable serotonergic modulation[22].
Alpha-adrenergic receptors: Alpha-2 receptors mediate catecholaminergic effects[23].
The CVLM is a critical component of the baroreceptor reflex arc:
This negative feedback loop maintains blood pressure homeostasis[24].
CVLM neurons provide tonic inhibition of sympathetic nerve activity:
Basal sympathoinhibition: Continuous GABAergic output to RVLM maintains appropriate sympathetic tone[25].
Reflex-mediated sympathoinhibition: Baroreceptor activation enhances CVLM activity, reducing sympathetic outflow[26].
The CVLM-RVL M pathway acts as a buffer against blood pressure fluctuations:
Pressor responses: CVLM activation limits excessive sympathetic activation[27].
Depressor responses: Withdrawal of CVLM tone allows RVLM activation during hypotension[28].
CVLM neurons integrate respiratory and cardiovascular information:
Respiratory sinus arrhythmia: CVLM activity modulates heart rate changes during respiration[29].
Cardioinhibitory responses: The CVLM contributes to reflex bradycardia[30].
The CVLM participates in chemoreceptor reflex pathways:
Central chemoreception: CVLM neurons detect changes in CSF pH and contribute to respiratory adjustments[31].
Peripheral chemoreceptor integration: Inputs from carotid body afferents are processed through CVLM circuits[32].
MSA is characterized by profound autonomic failure, and CVLM involvement is central to this pathophysiology:
Baroreflex failure: Degeneration of CVLM neurons contributes to impaired blood pressure regulation[33].
Orthostatic hypotension: Loss of CVLM-mediated sympathoinhibition results in inadequate pressor responses to standing[34].
Supine hypertension: compensatory mechanisms in surviving neurons may contribute to elevated nighttime blood pressure[35].
Autonomic dysfunction: CVLM pathology may contribute to cardiovascular dysregulation in PD[36].
Blood pressure instability: Both orthostatic hypotension and supine hypertension are common in PD[37].
Non-motor symptoms: Autonomic dysfunction often precedes motor symptoms, suggesting early CVLM involvement[38].
Isolated autonomic failure: PAF involves selective degeneration of autonomic neurons, including those in the CVLM[39].
Baroreceptor dysfunction: Impaired baroreflex function is a hallmark of PAF[40].
Cardiovascular dysregulation: CVLM involvement contributes to diabetic cardiovascular autonomic neuropathy[41].
Orthostatic intolerance: Impaired sympathetic reflex responses result in dizziness and syncope[42].
Rodent models: Rats and mice provide accessible models for studying CVLM anatomy and function[43].
Rabbit studies: The rabbit has been particularly important for cardiovascular reflex studies[44].
Genetic models: Transgenic mice enable study of specific neurotransmitter systems[45].
Brain slice preparations: Acute medullary slices enable electrophysiological characterization of CVLM neurons[46].
Primary culture: Dissociated neuron cultures allow detailed molecular studies[47].
Baroreflex sensitivity testing: Evaluating baroreceptor-CVLM-RVLM function provides information about autonomic integrity[48].
Heart rate variability: Analysis of HRV reflects CVLM-mediated autonomic modulation[49].
Tilt-table testing: Evaluates orthostatic tolerance and CVLM function[50].
Midodrine: Alpha-1 agonist used to treat orthostatic hypotension by compensating for CVLM dysfunction[51].
Fludrocortisone: Mineralocorticoid expands blood volume to address orthostatic intolerance[52].
Beta-blockers: May help manage supine hypertension in autonomic failure[53].
Clonidine: Central alpha-2 agonist can modulate sympathetic outflow[54].
Immunohistochemistry: Characterization of neurochemical phenotypes[55].
Tracing studies: Viral and anatomical tracers map connectivity[56].
Focal lesions: Chemical or electrolytic lesions study function[57].
Electrophysiology: Extracellular and intracellular recordings characterize neuronal properties[58].
Optogenetics: Genetic targeting enables precise manipulation of specific populations[59].
Chemogenetics: DREADD technology allowsDesigner receptor manipulation[60].
The caudal ventrolateral medulla represents a critical node in autonomic cardiovascular regulation. Through GABAergic projections to the RVLM, CVLM neurons provide essential inhibitory control of sympathetic nerve activity, mediating baroreceptor reflexes and maintaining blood pressure homeostasis. Degeneration of CVLM neurons in neurodegenerative diseases such as MSA and PD contributes to profound autonomic dysfunction. Understanding CVLM physiology provides insights into autonomic failure and potential therapeutic approaches.
Caudal Ventrolateral Medulla Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Caudal Ventrolateral Medulla Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci. 2006 ↩︎
Pilowsky PM, et al. CVLM anatomy and connections. J Comp Neurol. 2005 ↩︎
Marson L. GABAergic projections to RVLM. J Comp Neurol. 1997 ↩︎
Stornetta RL. Glycinergic neurons in CVLM. J Neurosci. 2009 ↩︎
Goodchild AK. Glutamate in CVLM interneurons. Neuroscience. 2002 ↩︎
Howe MW. Catecholaminergic neurons in medulla. J Comp Neurol. 2015 ↩︎
Cunnington D. NTS to CVLM transmission. J Neurophysiol. 2011 ↩︎
Sawchenko PE. Area postrema connections to CVLM. J Comp Neurol. 1983 ↩︎
Cunningham JT. Hypothalamic inputs to CVLM. Brain Res. 2002 ↩︎
Holdstock NJ. Raphe projections to CVLM. Neuroscience. 1996 ↩︎
Schreihofer AM. CVLM to RVLM GABAergic projection. J Neurophysiol. 1997 ↩︎
Strack AM. Spinal projections from CVLM. J Comp Neurol. 1989 ↩︎
Lipski J. Barosensitive neurons in CVLM. J Neurophysiol. 1996 ↩︎
Casati M. Respiratory modulation of CVLM neurons. J Appl Physiol. 2012 ↩︎
Bouryi VA. Calcium currents in CVLM neurons. J Neurophysiol. 2003 ↩︎
Jackson AR. Potassium channels in CVLM neurons. Neuroscience. 2004 ↩︎
Biel M. HCN channels in cardiovascular neurons. Nat Rev Neurosci. 2009 ↩︎
Aicher SA. Glutamate receptors in CVLM. J Comp Neurol. 2002 ↩︎
Nalivaiko E. Serotonin receptors in CVLM. J Appl Physiol. 2005 ↩︎
Matsumura K. Alpha-adrenergic receptors in CVLM. Am J Physiol. 1998 ↩︎
Abboud FM. Sympathoinhibition from CVLM. Hypertension. 2012 ↩︎
Dampney RA. Pressor response from CVLM. J Auton Nerv Syst. 1994 ↩︎
Imaizumi T. CVLM in depressor responses. Am J Physiol. 1984 ↩︎
Karemaker JM. Respiratory sinus arrhythmia. Auton Neurosci. 2002 ↩︎
Verberne AJ. Cardioinhibitory responses from CVLM. Neuroscience. 2006 ↩︎
Guyenet PG. Central chemoreception. Respir Physiol Neurobiol. 2007 ↩︎
Nattie E. Chemoreceptor integration. J Appl Physiol. 2001 ↩︎
Wenning GK. Orthostatic hypotension in MSA. Mov Disord. 2000 ↩︎
Vinik AI. Diabetic autonomic neuropathy. Diabetes Care. 2003 ↩︎
Freeman R. Orthostatic intolerance in diabetes. Neurology. 2005 ↩︎
Korner PI. Rabbit cardiovascular studies. Physiol Rev. 1994 ↩︎
Paton JF. Brain slice preparation for CVLM. J Neurosci Methods. 1993 ↩︎
Stornetta RL. Primary culture of medullary neurons. Methods. 2003 ↩︎
La Rovere MT. Baroreflex sensitivity testing. Eur Heart J. 2001 ↩︎
Task Force of ESC. Heart rate variability standards. Circulation. 1996 ↩︎
Jankovic J. Midodrine in autonomic failure. Mov Disord. 1993 ↩︎
Grundy D. Fludrocortisone in autonomic failure. Clin Sci. 1982 ↩︎
Shannon JR. Beta-blockers for supine hypertension. Circulation. 2000 ↩︎
Robertson D. Clonidine in autonomic failure. Hypertension. 1981 ↩︎
Matsuguchi H. Immunohistochemistry of CVLM neurons. J Comp Neurol. 1982 ↩︎
Leong SK. Tracing medullary connections. J Neurosci Methods. 1984 ↩︎
Barman SM. Electrophysiology of RVLM neurons. J Neurophysiol. 1990 ↩︎
Ray RS. Optogenetic manipulation of CVLM. Nat Neurosci. 2011 ↩︎
Armbruster BN. DREADD technology. Proc Natl Acad Sci U S A. 2007 ↩︎